sickle cell disease in the host countries. Many patients fled to Western and Northern European countries where hemoglobinopathies were very rare and where the healthcare systems were unable to cope with this sudden increase in patient numbers and complications. For example, disease characteristics were much more pronounced than doctors were used to. Complications occurred that physicians only knew from textbooks. In addition, virtually all families needed significant help in psychosocial matters and many refugees were severely traumatized.
Methods
In addition to an extensive review of the literature, international experts for haemoglobin disorders were contacted via email and asked to take part in an online survey. They were asked if and how relevant migration is for their clinical practise, if they did observe changes in the number of patients during the last five years and if and how they responded to these changes.
Results
The results of this survey are pending and will be presented and discussed at the TIF conference. ©Copyright S. Lobitz, 2018 Licensee PAGEPress, Italy Thalassemia Reports 2018 8:7471 doi:10.4081/thal.2018.7471 
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